SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-257368
Filing Date
2010-11-12
Accepted
2010-11-12 06:16:00
Documents
3
Period of Report
2010-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17194
2 TRIUS THERAPEUTICS, INC. PRESS RELEASE DATED NOVEMBER 11, 2010 dex991.htm EX-99.1 77397
3 GRAPHIC g117353g83y50.jpg GRAPHIC 14319
  Complete submission text file 0001193125-10-257368.txt   115990
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34828 | Film No.: 101182315
SIC: 2834 Pharmaceutical Preparations